REVISTA ESPAÑOLA DE
CARDIOLOGÍA
ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 77. Num. 7.
Pages 597-598 (July 2024)

Letter to the editor
In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease

En reconocimiento del origen español del CRISPR/Cas9. Implicaciones para el tratamiento de las cardiopatías familiares

María Sabater MolinaaJuan Ramón Gimeno Blanesb
Gene therapy for heart failure and cardiomyopathies
Rev Esp Cardiol. 2023;76:1042-5410.1016/j.rec.2023.06.009
Alessia Argirò, Jeffrey Ding, Eric Adler
In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease. Response
Rev Esp Cardiol. 2024;77:598-910.1016/j.rec.2024.03.007
Alessia Argirò, Jeffrey Ding, Eric Adler
https://doi.org/10.1016/j.rec.2024.01.007
View PDF
Lea este artículo en español
Share

Options

Imagen extra
Rev Esp Cardiol. 2024;77:597-8

Identify yourself

Not yet a subscriber to the journal?

Revista Española de Cardiología (English Edition)
Subscribe to the journal

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960

E-mail

atencionalcliente@elsevier.com
Copyright © 2024. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?